ESPNDon't look now, Michiganders, but you're back in the Bottom 10RTP Desporto12h30 Aviso a CR7: "Jesus não vira cara à luta"The Jerusalem PostMaine Senate candidate Troy Jackson opposes US giving Israel 'blank check'PunchTinubu mourns NADECO chieftain Ralph ObiohaVanguardIGP Disu mourns 25 NAF personnel, passengers killed in crashRapplerAnyare? Villars’ AllHome, AllDay confirm store closuresCollider‘Carrie’s Mike Flanagan Confirms Why He Made a Major Change From Stephen King’s BookSouth China Morning PostChinese consortium to build Latin America’s longest cable-stayed bridge in BrazilZDF heuteAktuelle Pressemitteilungen des ZDFVariety‘In the Shadows’ Producers to Self-Release British Boxing Biopic Following Collapse of U.K. Distributor True Brit Entertainment (EXCLUSIVE)UN NewsWHO releases first global guidelines on child obesity as cases surgeTagesschauFrüherer BND-Präsident Hanning muss in Untersuchungshaft
KioskNews
The Daily Newsstand · Free, Always
Wednesday, October 7, 2026
Language
Seeking Alpha·United States·

Boston Scientific names Joseph M. Fitzgerald COO, restructures into three reportable segments

Translate

Deepa Sarvaiya

  • Boston Scientific Corporation (BSX) said on Oct. 7, 2026 that it will appoint Joseph M. Fitzgerald as executive vice president and chief operating officer, effective Jan. 1, 2027.
  • The company will reorganize its reporting structure into three reportable segments: Interventional Therapies, Rhythm Solutions and MedSurg, also effective Jan. 1.
  • Fitzgerald will oversee the company's global operations, business units and regions. Under the new operating model, each segment will be led by an executive who will report to Fitzgerald.
  • Press Release

Create Your Free Account to Keep Reading

Get the confidence to navigate an uncertain market with free breaking news and stock alerts.

View the original on Seeking Alpha →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.